Skip to main content

Table 2 Baseline patient characteristics

From: Clinical experience regarding safety and diagnostic value of cardiovascular magnetic resonance in patients with a subcutaneous implanted cardioverter/defibrillator (S-ICD) at 1.5 T

ParameterValue
Age, years48 ± 12
Gender male/female, n (%)13 (57%) / 10 (43%)
Height, cm179 ± 9
Weight, kg87 ± 18
BMI, kg/m227 ± 4
BSA, m22.0 ± 0.2
NYHA class I / II / III / IV, n (%)11 (48%) / 5 (22%) / 3 (13%) / 0 (0%)
Indication for S-ICD implantation, n (%)
Suspected non-ischemic cardiomyopathy with LVEF ≤35%5 (22%)
Suspected ischemic cardiomyopathy with LVEF ≤35%1 (4%)
Ventricular arrhythmia of unknown origin17 (74%)
Primary vs. secondary prophylaxis, n (%)8 (35%) vs. 15 (65%)
  1. BMI body mass index; S-ICD subcutaneous implanted cardioverter/defibrillator; LVEF left ventricular ejection fraction